Concepedia
Statistics
Publications
4
Citations
140
H-Index
Active since
2022
Affiliations
Emory University(Current)
Astellas Pharma (United States)
Moffitt Cancer Center
Asari Ekpenyong is an author at Emory University specializing in oncology, pharmacology, and medicine.
Publications per year
2022–2024
Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
Nabil F. Saba, Conor Steuer, Asari Ekpenyong et al. · Nature Medicine · 2023 · 76 citations · Full text
Medicine, Oncology, Pharmacology +12
HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer
Fanghui Chen, Chris Tang, Fan Yang et al. · Science Advances · 2024 · 34 citations · Full text
Medicine, Oncology, Pharmacology +17
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma
Nabil F. Saba, Stuart J. Wong, Tahseen H. Nasti et al. · JAMA Oncology · 2024 · 18 citations · Full text
Medicine, Oncology, Radiation Oncology +17
A phase II trial of pembrolizumab and cabozantinib in patients (pts) with recurrent metastatic head and neck squamous cell carcinoma (RMHNSCC).
Nabil F. Saba, Asari Ekpenyong, Ashley McCook-Veal et al. · Journal of Clinical Oncology · 2022 · 12 citations
1–4 of 4